Microdosing

How GLP-1 microdosing is actually done, if you’re considering it

Evidence-sourced

Written and fact-checked to our published editorial standards.Last updated 2026-07-26. Every clinical claim on this page is sourced to a named primary authority, listed at the foot of the page — see how we research, source, and correct our work.

Direct answer

What you need to know

Evidence strength: Not established

The single biggest safety factor is whether a prescriber who knows your history is involved. There is no clinical trial data showing microdosing works, and the practice is not endorsed by AACE. This page describes how it is done in practice for people who are going to look it up either way. It is not a recommendation, and it is deliberately not a set of instructions.

Key takeaways

Supervised and self-directed are not two versions of the same thing. They carry different risks.
Self-measuring a fraction of a dose is harder than it sounds, and the errors are unit errors.
Read the evidence overview first — the case for doing this at all is weaker than most sources imply.
There are things on this page we will not describe, and we say which.

Important limitation: We cannot tell you a safe microdose, because no trial has established one and we will not invent a number. Anything here describes what is reportedly done, not what is known to work.

Next action: Ask a prescriber directly rather than adapting a protocol from a forum. If the answer matters enough to search for, it matters enough to have supervised — and our directory lists providers who require a genuine evaluation.

Primary sources: FDA, DailyMed — FDA labels

General education, not medical advice, and not an endorsement of microdosing.

Supervised versus self-directed: the distinction that matters most

“Microdosing” covers two very different things that get talked about as one:

A prescriber intentionally keeping you at a low, approved-increment dose — for example, staying at an early titration step longer than the standard schedule because that is where you tolerate the medication, under their monitoring. This uses the same approved-strength pens as standard treatment; it is a dosing decision, not a different product.
Buying a compounded product marketed specifically as a “microdose,” or measuring a fraction of a dose yourself — this is the version with the documented safety problems: inconsistent compounded dosing, and real measurement error from self-splitting a dose designed to be given as a single unit.

The first is a legitimate clinical conversation to have with your prescriber. The second is the version physicians are specifically warning about.

Why self-measuring a fraction of a dose is riskier than it sounds

Standard GLP-1 injector pens are designed to deliver a specific, fixed dose reliably; they are not designed as a "draw out a fraction" device, and doing so introduces real measurement error. Compounded products sold specifically as microdoses add a second layer of uncertainty, since the FDA does not review compounded formulations for manufacturing consistency the way it does an approved product — meaning the actual dose in the vial may not precisely match the label.

If you are going to raise this with a prescriber, ask

“Is there a clinical reason to keep me at a lower dose longer, rather than following the standard titration schedule?”
“If I’m struggling with side effects, is a supervised dose reduction the right move instead?”
“Are you able to prescribe and monitor an off-label low-dose approach, or is that outside what you offer?”
“What would you actually want to monitor if we did this?”

What we would not recommend

Buying a product marketed as a “GLP-1 microdose” from a seller who has not evaluated your medical history.
Drawing a fraction of a standard-strength pen yourself without a clinician specifically instructing you how and confirming the resulting dose.
Treating microdosing as a lower-risk or “gentler” alternative to standard treatment — the evidence gap, not the dose size, is the actual issue.

For the underlying reasoning on why doses are structured the way they are at all, see our dosing and titration guide. For the mechanism these medications rely on, see how GLP-1 medications work.

Sources

Each source below supports specific statements on this page. We cite the strongest available authority and verify against the current version before publishing.

Can microdosing GLP-1s promote health and weight loss?Cedars-Sinai (expert commentary)Supports: The description of self-directed use as 'not a safe or evidence-based workaround' and the specific harms named.
FDA-approved prescribing information (drug labels)DailyMed, U.S. National Library of MedicineSupports: The approved dose increments a microdose is calculated as a fraction of.
Drug approvals, labeling and safety communicationsU.S. Food & Drug AdministrationSupports: FDA guidance on safe use of injectable devices and reports of compounding-related dosing errors.

This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.